Novo Nordisk stock rose after the Danish pharma giant posted better-than-expected quarterly earnings, but cuts its guidance ...

This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...

Andy Richter said he looked into taking weight-loss drugs despite not having type 2 diabetes. However, his insurance company ...

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...

The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...

When it came to cardiovascular incidents, the report showed major gains for GLP-1 users, too. 44% experienced fewer ...

India conducted strikes on nine terrorist sites in Pakistan. The action comes in response to the terrorist attack in Pahalgam ...

Full Frame Growth Partners is a minority investor in California-based Supergut, a company making powdered supplements and ...

Novo Nordisk slashed its 2025 sales forecast citing lower-than-expected penetration of its branded GLP-1 weight loss and ...